A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Hackensack Meridian Health
Stanford University
Baylor College of Medicine
Gilead Sciences
Gilead Sciences
Hoffmann-La Roche
Allogene Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Sanofi
Weill Medical College of Cornell University
Affimed GmbH
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Vanderbilt-Ingram Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Hoffmann-La Roche
Gilead Sciences
Hoffmann-La Roche
Stanford University
Celgene
Gilead Sciences
M.D. Anderson Cancer Center
Gilead Sciences
University of Alabama at Birmingham
Gilead Sciences
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center